['hyperuricemia', 'albuminuria', 'type 2 diabetes']
['verinurad 9 mg+febuxostat 80 mg', 'placebo']

        Inclusion Criteria:

          -  Serum Uric Acid ≥6.0 mg/dL

          -  eGFR ≥30 mL/min/1.73 m2

          -  UACR between 30 mg/g and 3500 mg/g inclusive

          -  Diagnosed with T2DM

        Exclusion Criteria:

          -  Treated with any drug for hyperuricemia in the 6 months preceding randomization.Drugs
             for hyperuricemia include all XO inhibitors (allopurinol, febuxostat and topiroxostat)
             and URAT1 inhibitors (lesinurad, verinurad, probenecid, and benzbromarone)

          -  Prior history of gout, unless prophylaxis therapy isn't required

          -  Patients who are pregnant, lactating, or planning to become pregnant

          -  Patients unsuitable or unable to undergo MRI assessment
      